|
|
|
|
FOR IMMEDIATE RELEASE
MULTICASE Inc. Announces a renewal of Cooperative Research And Development Agreement with the Food and Drug Administration.CLEVELAND, Ohio · Octover 1, 2004 · MULTICASE Inc., a leading supplier of
Artificial Intelligence Software for the development of new drugs and the
assessment of their biological activities, today announced that it had renewed
the Cooperative Research and Development Agreement (CRADA) with the U.S. Food
and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER)
for another five years.
Under this CRADA, the FDA will use the Company’s M-CASE Software to develop a
panel of toxicity database modules to provide toxicology decision support
information for regulatory, research and development applications. The principal
investigators for the FDA are Dr. Joseph F. Contrera and Dr. Edwin J. Matthews
in the Office of Research and Testing.
|
|
Send mail to
saiakhov@multicase.com with
questions or comments about this web site.
|
